Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30) | PAR 17 095

Opportunity Information: Apply for PAR 17 095

The Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30), listed under funding opportunity number PAR-17-095, is a National Institutes of Health (NIH) grant program (CFDA 93.397) designed to provide core institutional support for cancer centers that are designated by the National Cancer Institute (NCI). The grant is not aimed at funding a single research project. Instead, it is meant to strengthen and organize a cancer center as an integrated, high-performing research enterprise by supporting the shared infrastructure, coordination, and central capabilities that allow many different investigators and research programs to work together effectively.

This FOA supports two categories of NCI-designated centers. The first is Comprehensive Cancer Centers, which are expected to show meaningful depth and breadth across three major research areas: basic laboratory research, clinical research, and prevention, control, and population-based research. A defining expectation for comprehensive centers is substantial transdisciplinary work that connects these areas, meaning the center should be structured in a way that actively encourages research that crosses traditional departmental and scientific boundaries. The second category is Cancer Centers, which may focus primarily on one or a combination of these research areas, without necessarily demonstrating the same across-the-board breadth required of comprehensive centers. In both cases, the core idea is that the center is more than a collection of independent labs or clinics; it is a coordinated program with shared direction and integrated scientific goals.

The purpose of the CCSG mechanism is to help cancer centers capitalize on the full range of cancer-related research capabilities within their institutions and bring them together into a single, unified, and collaborative structure. The FOA emphasizes integration of meritorious research programs spanning laboratory science, clinical investigation, and population science into one transdisciplinary enterprise, explicitly reaching across institutional boundaries. In practical terms, the grant is intended to support the organizational backbone that makes large-scale cancer research possible: shared resources that multiple research teams can use, systems for coordination and collaboration, and administrative and scientific structures that help the center operate as a cohesive unit rather than as separate silos.

Centers funded under this announcement are expected to function as major drivers of progress in understanding cancer and improving how it is prevented, diagnosed, and treated. The FOA highlights several core expectations: serving as a major source of discovery about the nature of cancer; contributing to the development of more effective approaches to prevention, diagnosis, and therapy; and significantly advancing the development of shared research resources that support a broad range of investigators. The centers are also expected to collaborate and coordinate with other NCI-funded programs and investigators, which signals that NCI views these centers as key nodes in a national research network rather than purely local or institution-specific entities. Another central expectation is dissemination of research findings for the benefit of the community, reflecting a strong emphasis on ensuring that knowledge and advances extend beyond the academic setting and reach patients, practitioners, and the broader public.

Eligibility for this opportunity is broad across U.S.-based organizations and includes multiple types of governmental entities and institutions. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; and federally recognized Native American tribal governments. The eligible applicant pool also includes public housing authorities/Indian housing authorities, and Native American tribal organizations other than federally recognized tribal governments. Nonprofit organizations are eligible whether or not they have 501(c)(3) status, and for-profit organizations other than small businesses and small businesses are also listed among eligible applicants, along with an "other" category that can cover additional types depending on NIH rules and the specific institutional context.

The FOA also explicitly calls out additional eligible applicant categories that reflect an intent to include a wide range of institution types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible agencies of the federal government, tribal governments that are not federally recognized, and U.S. territories or possessions. At the same time, the opportunity is clear about geographic restrictions: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed.

Administratively, the sponsoring agency is NIH, and the opportunity is categorized as a discretionary grant program in the education and health activity area. The source data lists an original closing date of 2019-11-04 and a creation date of 2016-12-21, which indicates this specific announcement is tied to that historical application window and publication cycle. The award ceiling and expected awards fields are not specified in the provided data, which is consistent with NIH programs where award size is often determined by budget justification, allowable costs, the scope of the center, and NCI programmatic considerations rather than a single fixed cap.

Overall, this CCSG P30 opportunity is best understood as institutional support for NCI-designated cancer centers to build and maintain the shared research ecosystem that enables high-impact, collaborative cancer research. Its central themes are integration across basic, clinical, and population sciences; strong transdisciplinary collaboration; development and operation of shared resources; coordination with the broader NCI research portfolio; and active dissemination of knowledge and advances to benefit the community.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.397.
• This funding opportunity was created on 2016-12-21.
• Applicants must submit their applications by 2019-11-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 17 095

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: